Zhongheng Group: Company has temporarily suspended the public solicitation process for partial share transfer of Laimeiyao Pharmaceutical

NightAirdropper · 2026-03-12T22:45:26+00:00

Zhongheng Group stated on the investor interaction platform that the share transfer work of Laimeikang Pharmaceuticals has been temporarily suspended, but related matters are still being promoted, and will comply with information disclosure obligations.

NightAirdropper

2026-03-12 22:45:26

Abstract generation in progress

Everyday Economic News AI Express: An investor asked on the investor interaction platform, “When will the transfer of Laimei Pharmaceuticals be initiated?”

Zhongheng Group (600252.SH) stated on March 10 on the investor interaction platform that the company has temporarily suspended the public solicitation process for the transfer of some shares of Laimei Pharmaceuticals. The related matters are progressing in an orderly manner, and the company will fulfill its information disclosure obligations based on the progress of this matter. Thank you for your attention.

(Reporter Zeng Jianhui)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Verify before use. Operate at your own risk.

Daily Economic News

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.